Nancy J. Brown, MD

Nancy J. Brown, MD

Dean, Yale School of Medicine

Nancy J. Brown, MD, became the Jean and David W. Wallace Dean of Medicine and C.N.H. Long Professor of Internal Medicine at Yale School of Medicine in February of 2020. Dr. Brown graduated from Yale College, where she majored in molecular biophysics and biochemistry. She earned her medical degree from Harvard University. She completed internship and residency programs in medicine at Vanderbilt University, where she also did a fellowship in clinical pharmacology. Dr. Brown joined the faculty of Vanderbilt in 1992 and held a number of leadership positions, serving as chief of the Division of Clinical Pharmacology, associate dean for clinical and translational scientist development, and Robert H. Williams professor before becoming the Hugh J. Morgan Chair of Medicine and physician-in-chief of Vanderbilt University Hospital in 2010.

Dr. Brown has long been committed to medical education and mentorship. At Vanderbilt, she established the Elliot Newman Society to support the development of physician-scientists and co-founded the Vanderbilt Master of Science in Clinical Investigation program. Her research has defined the molecular mechanisms through which commonly prescribed blood pressure and diabetes drugs affect the risk of cardiovascular and kidney disease. In her clinical practice, she has treated patients with resistant and secondary forms of hypertension. Dr. Brown has served as a member of the NIH National Advisory Research Resources Council and the National Heart, Lung, and Blood Advisory Council. She was president of the Association of Professors of Medicine. Her numerous awards include election to the American Society for Clinical Investigation, the Association of American Physicians, and the National Academy of Medicine. In 2019, she was elected a Master of the American College of Physicians.

Gary Desir, MD

Chair of the YM Board

Gary V. Desir, MD, chair of the Yale Medicine (YM) Board, oversees a group of clinical department chairs and four at-large faculty members who provide direction and guidance for the administrative leaders of Yale Medicine. Dr. Desir is the Paul B. Beeson Professor of Medicine at Yale School of Medicine (YSM), and holds multiple leadership positions, including chair of medicine at both YSM and the Veterans Affairs Connecticut Health System. He is a physician-scientist whose major contributions include the discovery a specific voltage-gated potassium channel that regulates body weight and insulin sensitivity, and the identification of a new growth factor named renalase that protects cells against toxic and ischemic injury. Dr. Desir completed his medical degree at YSM, and trained in internal medicine and nephrology at Yale New Haven Hospital. He is the cofounder of the minority organization for retention and expansion (MORE), a faculty group at YSM focused on increasing faculty diversity through mentoring programs and developing resilient social networks.

Paul Taheri, MD, MBA

Chief Executive Officer

Paul Taheri, MD, MBA, chief executive officer (CEO) of Yale Medicine (YM) and deputy dean for Clinical Affairs at Yale School of Medicine, provides leadership for a rapidly expanding physician organization that combines the most cutting-edge medicine and with the best compassionate care. He joined YM from University of Vermont (UVM), where he was president and CEO of the UVM Medical Group in Burlington, and a professor of surgery. Dr. Taheri, who is originally from Buffalo, New York, completed his medical degree at New York University and his general surgical residency at Tulane University, and has experience as a trauma surgeon. He completed his MBA at the University of Michigan Ross School of Business. Yale Medicine’s CEO is also the past chair of the Group on Faculty Practices for the Association of American Medical Colleges and an examiner for the American Board of Surgery. He has lectured broadly on various business topics, including cost of care, physician leadership and system optimizations.

Frederick Borrelli, MBA, MA

Chief Administrative Officer

Frederick Borrelli, MBA, MA, chief administrative officer (CAO) for Yale Medicine, provides leadership and strategic oversight for the practice’s staff and facilities, in addition to supporting the overall administration. He directs, plans and manages comprehensive business affairs, and provides management and analysis of budgets, program development, human resources, staff training and development, facilities management and regulatory compliance. Borrelli has worked in health care for more than 20 years. He is the former COO of Yale’s clinical practice; prior to that he was associate chair and chief of administration in the Department of Surgery. Before coming to Yale, he was vice chair of finance and administration for the University of Rochester Medical Center. Borrelli has master’s degrees in both medical management and business administration from the University of Rochester’s William E. Simon Graduate School of Business Administration.

Iain Burchell, MBA

Chief Financial Officer

Iain Burchell, MBA, chief financial officer (CFO) of Yale Medicine (YM), has primary responsibility for strategic financial leadership, including management of the operating budget and capital budgets, the clinical revenue cycle, and financial reporting systems. Burchell joined YM from University of Texas (UT) Southwestern Medical Center in Dallas, where he had served as CFO of the faculty practice since 2009. He began his career at UT Southwestern in 2003 as the assistant vice president of health system planning after several years in various roles at American Airlines. A graduate of Glasgow University in Scotland, Burchell completed his MBA in operations management at the McCombs School of Business at the University of Texas in Austin.

Kimbirly Moriarty, MS

Chief of Network Strategy

Kimbirly Moriarty, MS, chief of Network Strategy for Yale Medicine (YM), is responsible for strategic planning and business development. Moriarty leads the centralization of YM’s efforts toward building its physician network, strategic alliances and partnerships, ambulatory planning, and clinical program development. Moriarty joined YM in early 2014 from New York University Langone Medical Center, where she was director of physician network development and integration, providing leadership for development and expansion of the clinical network throughout the five boroughs, in addition to Long Island, Westchester and the Hudson Valley region. Prior to that, she was CEO at Murray Hill Medical Group, P.C., an NYULMC affiliate. Moriarty completed her bachelor’s degree in business at University of Vermont and her master’s in administrative studies at Boston College.

Maryam Saeri, MBA

Chief Operating Officer

Maryam Saeri, MBA, chief operating officer (COO) of Yale Medicine, has comprehensive oversight of Yale Medicine’s clinical practices, steering the increasing focus on clinical optimization and leading such areas as clinical operations, infrastructure development, patient access and experience, and practice integration. Saeri joined Yale School of Medicine in December 2013, when she became vice chair of Finance and Administration in the Department of Pediatrics. Shortly after her arrival, she assumed additional responsibility for the department’s clinical operations. Before coming to Yale, Saeri was at the University of British Columbia and the British Columbia Children’s Hospital in Vancouver, Canada, where she held a rare dual appointment in both institutions as senior director for administration and patient care services. She earned her BSc in biopsychology and her MBA with a healthcare concentration at the University of British Columbia.

Babar Khokhar, MD, MBA

Babar Khokhar, MD, MBA

Chief Clinical Transformation Officer

Babar Khokhar, MD, MBA, and assistant professor of neurology, oversees clinical optimization, population health, and clinical innovation for Yale Medicine. Dr. Khokhar and his team are focused on enhancing the patient and provider experience and identifying efficient ways of managing diverse patient populations with an eye toward achieving better outcomes, lower costs, and greater value. In 2015, prior to his current role, Dr. Khokhar created the clinical optimization team, which worked with a number of departments and centers. He obtained his MD and MBA in Healthcare Management in a combined program at Tufts University. After completing his residency in neurology at Yale New Haven Hospital, he went on to complete a fellowship in neuromuscular medicine at the School of Medicine and the Veterans Administration. He serves as the vice-chairman of operations, chief of the General Neurology Section and director of the MDA-ALS Clinic in the Department of Neurology and medical director of the Yale New Haven Hospital Electromyography Laboratory.

Steven Choi, MD

Steven Choi, MD

Chief Quality Officer

Steven Choi, MD, is the inaugural chief quality officer for Yale Medicine and Yale New Haven Health System. He is responsible for developing and executing a single, unified strategy for quality and safety across all inpatient and ambulatory clinical practice sites. He spent the first two decades of his career caring for critically ill children, serving as the medical director of several cardiac intensive care units, before transitioning to health care quality leadership. A pediatric cardiac intensivist, Dr. Choi joined Yale from Montefiore Health System in New York, where he served as assistant vice president and director of Montefiore Network Performance Improvement. He was instrumental in the development of an integrated performance improvement plan for the Montefiore Health System and improved performance against publicly reported quality indicators. Dr. Choi is a seasoned quality improvement leader, having completed formal training with Intermountain Healthcare Delivery Improvement, University of Michigan Lean Healthcare and Kata Coaching, Lockheed Martin Six Sigma, and Northwestern University Organizational Leadership programs. Dr. Choi obtained his undergraduate degree from University of Pennsylvania and his medical degree from Robert Wood Johnson Medical School. He completed his pediatric residency training at Columbia University/Babies and Children’s Hospital of New York, and a critical care fellowship at University of Southern California School of Medicine/Children’s Hospital Los Angeles.